Search Results - "RODRIGUES, George B"

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial by Palma, David A, Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V, Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B, Yaremko, Brian P, Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S, Laba, Joanna, Qu, X Melody, Warner, Andrew, Senan, Suresh

“…The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites…”
Get full text

New Strategies in Stereotactic Radiotherapy for Oligometastases by Palma, David A, Louie, Alexander V, Rodrigues, George B

“…Patients with metastatic solid tumors are usually treated with palliative intent. Systemic therapy and palliative radiation are often used, with the goals of…”
Get full text

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial by Palma, David A, Olson, Robert, Harrow, Stephen, Correa, Rohann J M, Schneiders, Famke, Haasbeek, Cornelis J A, Rodrigues, George B, Lock, Michael, Yaremko, Brian P, Bauman, Glenn S, Ahmad, Belal, Schellenberg, Devin, Liu, Mitchell, Gaede, Stewart, Laba, Joanna, Mulroy, Liam, Senthi, Sashendra, Louie, Alexander V, Swaminath, Anand, Chalmers, Anthony, Warner, Andrew, Slotman, Ben J, de Gruijl, Tanja D, Allan, Alison, Senan, Suresh

“…Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose,…”
Get full text

Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons by Louie, Alexander V, Palma, David A, Dahele, Max, Rodrigues, George B, Senan, Suresh

“…Abstract The use of stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer is growing rapidly, particularly since it has become…”
Get full text

Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature by Huang, Kitty, Dahele, Max, Senan, Suresh, Guckenberger, Matthias, Rodrigues, George B, Ward, Aaron, Boldt, R. Gabriel, Palma, David A

“…Abstract Background Changes in lung density on computed tomography (CT) are common after stereotactic ablative radiotherapy (SABR) and can confound the early…”
Get full text

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer by Ashworth, Allison B, Senan, Suresh, Palma, David A, Riquet, Marc, Ahn, Yong Chan, Ricardi, Umberto, Congedo, Maria T, Gomez, Daniel R, Wright, Gavin M, Melloni, Giulio, Milano, Michael T, Sole, Claudio V, De Pas, Tommaso M, Carter, Dennis L, Warner, Andrew J, Rodrigues, George B

“…Micro-Abstract The management of patients with oligometastatic non–small-cell lung cancer (NSCLC) is controversial. The findings of this metaanalysis of 757…”
Get full text

A Primer on Interstitial Lung Disease and Thoracic Radiation by Goodman, Christopher D, Nijman, Suzan F M, Senan, Suresh, Nossent, Esther J, Ryerson, Christopher J, Dhaliwal, Inderdeep, Qu, X Melody, Laba, Joanna, Rodrigues, George B, Palma, David A

“…Interstitial lung disease (ILD) is a term used to describe a heterogeneous group of lung disorders with characteristic clinical and imaging features. Patients…”
Get more information

American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer by Amini, Arya, Verma, Vivek, Simone, Charles B., Chetty, Indrin J., Chun, Stephen G., Donington, Jessica, Edelman, Martin J., Higgins, Kristin A., Kestin, Larry L., Movsas, Benjamin, Rodrigues, George B., Rosenzweig, Kenneth E., Rybkin, Igor I., Slotman, Benjamin J., Wolf, Andrea, Chang, Joe Y.

“…Recent randomized studies have suggested improvements in progression-free and overall survival with the addition of stereotactic body radiation therapy (SBRT,…”
Get full text

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial by Palma, David A, Haasbeek, Cornelis J A, Rodrigues, George B, Dahele, Max, Lock, Michael, Yaremko, Brian, Olson, Robert, Liu, Mitchell, Panarotto, Jason, Griffioen, Gwendolyn H M J, Gaede, Stewart, Slotman, Ben, Senan, Suresh

“…Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose,…”
Get full text

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead? by Al-Shafa, Faiez, Arifin, Andrew J, Rodrigues, George B, Palma, David A, Louie, Alexander V

“…The oligometastatic state is a proposed entity between localized cancer and widely metastatic disease, comprising an intermediate subset of metastatic cancer…”
Get full text

Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors by Griffioen, Gwendolyn H.M.J, Toguri, Daniel, Dahele, Max, Warner, Andrew, de Haan, Patricia F, Rodrigues, George B, Slotman, Ben J, Yaremko, Brian P, Senan, Suresh, Palma, David A

“…Abstract Objectives Metastatic non-small cell lung carcinoma (NSCLC) generally carries a poor prognosis, and systemic therapy is the mainstay of treatment…”
Get full text

Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis by Palma, David A, Warner, Andrew, Louie, Alexander V, Senan, Suresh, Slotman, Ben, Rodrigues, George B

“…Micro-Abstract This systematic review identified 2 randomized studies examining the role of thoracic radiotherapy (TRT) in patients receiving platinum-based…”
Get full text

Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review by Chen, Hanbo, Louie, Alexander V, Boldt, R. Gabriel, Rodrigues, George B, Palma, David A, Senan, Suresh

“…Micro-Abstract Patient-reported outcomes are increasingly important in the evaluation of cancer treatment modalities. We systematically reviewed the existing…”
Get full text

Measuring the Population Impact of Introducing Stereotactic Ablative Radiotherapy for Stage I Non‐Small Cell Lung Cancer in Canada by Louie, Alexander V., Rodrigues, George B., Palma, David A., Senan, Suresh

“…Background. The Cancer Risk Management Model (CRMM) was used to estimate the health and economic impact of introducing stereotactic ablative radiotherapy…”
Get full text

Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial by Palma, David A, Chen, Hanbo, Bahig, Houda, Gaede, Stewart, Harrow, Stephen, Laba, Joanna M, Qu, X Melody, Rodrigues, George B, Yaremko, Brian P, Yu, Edward, Louie, Alexander V, Dhaliwal, Inderdeep, Ryerson, Christopher J

“…Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung…”
Get full text

Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial by Mendez, Lucas C, Arifin, Andrew J, Bauman, Glenn S, Velker, Vikram M, Ahmad, Belal, Lock, Michael, Venkatesan, Varagur M, Sexton, Tracy L, Rodrigues, George B, Chen, Jeff, Schaly, Bryan, Warner, Andrew, D'Souza, David P

“…Patients with high-risk prostate cancer are at increased risk of lymph node metastasis and are thought to benefit from whole pelvis radiotherapy (WPRT). There…”
Get full text

Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial by Yu, Edward, Allan, Alison L., Sanatani, Michael, Lewis, Debra, Warner, Andrew, Dar, A. Rashid, Yaremko, Brian P., Lowes, Lori E., Palma, David A., Raphael, Jacques, Vincent, Mark D., Rodrigues, George B., Fortin, Dalilah, Inculet, Richard I., Frechette, Eric, Bierer, Joel, Law, Jeffery, Younus, Jawaid, Malthaner, Richard A.

“…Abstract Background Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal…”
Get full text

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma by Correa, Rohann J M, Ahmad, Belal, Warner, Andrew, Johnson, Craig, MacKenzie, Mary J, Pautler, Stephen E, Bauman, Glenn S, Rodrigues, George B, Louie, Alexander V

“…Cytoreductive nephrectomy is thought to improve survival in metastatic renal cell carcinoma (mRCC). As many patients are ineligible for major surgery, we…”
Get full text

Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [ 18 F]FDG PET and CT perfusion: a prospective exploratory clinical study by Yang, Dae-Myoung, Palma, David A, Kwan, Keith, Louie, Alexander V, Malthaner, Richard, Fortin, Dalilah, Rodrigues, George B, Yaremko, Brian P, Laba, Joanna, Gaede, Stewart, Warner, Andrew, Inculet, Richard, Lee, Ting-Yim

“…Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging assessment of…”
Get full text

Evaluation of Health Economics in Radiation Oncology: A Systematic Review by Nguyen, Timothy K., MD, Goodman, Chris D., BMSc, Boldt, R. Gabriel, MSEd, MLIS, Warner, Andrew, MSc, Palma, David A., MD, PhD, FRCPC, Rodrigues, George B., MD, PhD, FRCPC, Lock, Michael I., MD, FRCPC, Mishra, Mark V., MD, Zaric, Gregory S., PhD, Louie, Alexander V., MD, MSc, FRCPC

“…Purpose Despite the rising costs in radiation oncology, the impact of health economics research on radiation therapy practice analysis patterns is unclear. We…”
Get full text